Ann: 2023 Annual Report to shareholders, page-25

TBH, I find that a typically specious post.

As you know, a suitor cannot just acquire 50.1% of a stock. Anything of 20% required a formal takeover offer.
Once that's made, the BoD will either recommend accepting or declining the offer.

How many hostile takeovers have there been in the Healthcare space recently, T?

Any potential suitor would likely want to get 90%+ of the stock to avoid dealing with minority shareholders. That means getting the BoD to recommend acceptance of the offer. The BoD, in their recommendation, cannot favour large shareholders over small share holders. They still have a fiduciary duty.

So, it's unlikely to be a case of whistling 'dixy' {sic} just yet.

PS: 6 months ago, you were happy to take $20 bucks and run. You could've taken the opportunity after the PMS trial results to sell, pretty sure there'll be another opportunity for you in a month or so.